Veronica Galvan, Ph.D., University of Texas Health Science Center at San Antonio (IMAGE)

The University of Texas at San Antonio Health Science Center

Veronica Galvan, Ph.D., University of Texas Health Science Center at San Antonio

Caption

Veronica Galvan, Ph.D., of the Barshop Institute at the University of Texas Health Science Center at San Antonio, co-authored a PLoS ONE paper that showed rapamycin treatment prevented learning and memory deficits in mice engineered to develop Alzheimer's disease.

Credit

UT Health Science Center San Antonio

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.